12/18/2024
8:30 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 8-K/A | |
11/21/2024
8:15 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:15 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:15 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
8:25 AM | Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
3:29 PM | Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Toh Kean Meng Melvin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/17/2024
3:30 PM | Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Yu Ying Choi Alan Abel (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
|
10/17/2024
3:29 PM | CK Life Sciences Intl Inc (0001297567) (Reporting)
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Sealbond Ltd (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/15/2024
3:19 PM | Sealbond Ltd (Filed by)
Virios Therapeutics (Subject)
Virios Therapeutics, Inc. (Subject)
| Form SC 13D | |
10/07/2024
7:06 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form DEFA14A | |
10/07/2024
7:02 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
9:15 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
8:30 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
8:15 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2024
8:15 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
8:28 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
9:30 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
7:01 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
4:25 PM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
4:26 PM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form ARS | |
04/25/2024
3:33 PM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form DEF 14A | |
03/01/2024
8:10 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/29/2024
8:25 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
11:43 AM | Gendreau Roger Michael (Reporting)
Virios Therapeutics (Issuer)
Virios Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
11:47 AM | Grosswald Ralph (Reporting)
Virios Therapeutics (Issuer)
Virios Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
11:51 AM | Virios Therapeutics (Issuer)
Virios Therapeutics, Inc. (Issuer)
Walsh Angela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
11:54 AM | De La Rosa Abel (Reporting)
Virios Therapeutics (Issuer)
Virios Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
11:40 AM | Duncan Gregory Scott (Reporting)
Virios Therapeutics (Issuer)
Virios Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
3:21 PM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form DEFA14A | |
02/13/2024
5:01 PM | Corday Brian David (Filed by)
Virios Therapeutics (Subject)
Virios Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
02/02/2024
3:31 PM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form DEF 14A | |
02/02/2024
3:31 PM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form DEF 14A | |
01/22/2024
8:33 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form PRE 14A | |
01/03/2024
6:05 AM | Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
